DexCom, Inc. - Common Stock — Cash Flow (NASDAQ:DXCM) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities 475.6 M442.5 M669.5 M748.5 M989.5 M1.44 B 1.78 B Cash from investing activities -1.02 B-216.1 M-521.5 M-507.2 M-207.5 M536 M 137.3 M Cash from financing activities 912.1 M10.4 M-552.5 M-318.6 M-734.8 M-1.69 B -1.72 B Free cash flow 475.6 M442.5 M669.5 M748.5 M989.5 M1.44 B 1.78 B

News

DXCM Secures Health Canada Authorization for Dexcom G7 15 Day CGM

Here's Why DexCom (DXCM) is a Strong Growth Stock

Here's Why You Should Retain DexCom Stock in Your Portfolio for Now

Earnings Preview: What To Expect From DexCom's Report

DexCom Stock: The Growth Thesis Still Needs To Be Proven (NASDAQ:DXCM)

Abbott vs. DexCom: Which CGM Stock Is the Better Option Right Now?

DexCom to Roll Out Reimagined Stelo App With Global Expansion Plans

DXCM Receives FDA Clearance for Stelo OTC CGM System for Children

Abbott's CGM Growth Story Stays Intact Despite Q1 Moderation

Here's Why DexCom (DXCM) is a Strong Growth Stock

Why DexCom (DXCM) is a Top Momentum Stock for the Long-Term

Clinical Wins Boost Dexcom Growth Story In Type 2 Diabetes - DexCom (NASDAQ:DXCM)